Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK
- PMID: 24622628
- PMCID: PMC3965826
- DOI: 10.1038/eye.2013.303
Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK
Comment in
-
Response to Dr Clearkin.Eye (Lond). 2014 Dec;28(12):1523. doi: 10.1038/eye.2014.205. Epub 2014 Sep 5. Eye (Lond). 2014. PMID: 25190530 Free PMC article. No abstract available.
-
Comment on 'Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK'.Eye (Lond). 2014 Dec;28(12):1522-3. doi: 10.1038/eye.2014.204. Epub 2014 Sep 5. Eye (Lond). 2014. PMID: 25190531 Free PMC article. No abstract available.
References
-
- CMO Letter England, Wales, NI, available at https://www.gov.uk/government/uploads/system /uploads/attachment_data/fi... .
-
- CMO Letter Scotland CMO2013(15) available at http://www.sehd.scot.nhs.uk/cmo/CMO(2013)15.pdf .
-
- Green Book—Herpes Zoster chapter, available at https://www.gov.uk/government/collections/immunisation-against-infectiou... .
-
- Electronic Medicines Compendium website, summary of product characteristics for Zostavax http://www.medicines.org.uk/emc/medicine/25927 .
-
- Miller E, Marshall R, Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol. 1993;4:222–230.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
